GME Logo

User login

User menu

GME Meeting Planner

Fourth Annual Psychopharmacology Update

Join fellow healthcare professionals for this symposium featuring the world's leading experts who will discuss the latest advances in the pharmacotherapy of anxiety disorders, mood disorders, schizophrenia, and more. 

Overview



This activity is jointly provided by Postgraduate Institute for Medicine and Global Medical Education. 

This symposium featuring the world's leading experts who will discuss the latest advances in the pharmacotherapy of anxiety disorders, mood disorders, schizophrenia, and more.

Discounted Room Block at JW Marriott, Washington, D.C.
GME is pleased to offer a discounted room rate for attendees at this meeting.  To make your reservations, please follow the link below or call the hotel directly and mention Global Medical Education.  We do expect rooms to sell out quickly, so please book your rooms early! 

Web Address: https://aws.passkey.com/gt/215885189?gtid=950e6352267391c7a333d7cc3c3191d2
Phone:  1-800-393-2503 (Reference the Global Medical Education Psychopharmacology group.)

This activity is supported by an independent educational grant from Neurocrine Biosciences, Sage, Shire, and Sunovion.

 

Target Audience

This activity is intended for physicians, physician assistants, nurse practitioners, psychologists, registered nurses and other healthcare professionals engaged in the care of patients with psychiatric disorders.

 

Educational Objectives

After completing this activity, the participant should be better able to:

  •  Implement evidence based pharmacotherapy for mood, anxiety disorders, and schizophrenia.

  •  Assess the latest advances in the management of postpartum depression.

  •  Employ the appropriate treatment of substance dependence.

  •  Evaluate the role of innovative treatments in treatment resistant depression.

  •  Provide appropriate care and counsel for patients and their families.

  •  Discuss the management of TD in psychiatric patients.

  •  Discuss the unmet needs in pharmacotherapy of ADHD across the lifecycle.

  •  Encourage the use of evidence based treatments for anxiety disorders.

  •  Discuss the role of ketamine to treat psychiatric disorders including the side effects and concerns.

  •  Individualize treatment choices, giving consideration to efficacy, safety, long-term data, and unique patient characteristics.

 

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Global Medical Education.  Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this live activity for a maximum of 13.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Continuing Pharmacy Education

Postgraduate Institute for Medicine designates this continuing education activity for 13.0 contact hour(s) (1.30 CEUs) of the Accreditation Council for Pharmacy Education.

(Universal Activity Number: JA4008162-9999-18-342-L01-P)

Type of Activity: Application

 

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 13.0 contact hours. Designated for 5.4 contact hours of pharmacotherapy credit for Advance Practice Registered Nurses.

 

Continuing Psychology Education

Postgraduate Institute for Medicine (PIM) is approved by the American Psychological Association to sponsor continuing education for psychologists.  PIM maintains responsibility for this program and its content.

This program offers 13.0 continuing education credits for psychologists.

 

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

 

Americans with Disabilities Act (required for live meetings only)

Event staff will be glad to assist you with any special needs (i.e., physical, dietary, etc). Please contact GME Customer Service prior to the live event at [email protected]

 

Fee Information

There is no fee for this educational activity.

Program Agenda

Tentative Agenda

Day 1 - Saturday, September 8

7:30 - 8:15 AM: Registration and Breakfast

8:15 - 8:30 AM: Opening Remarks by Chair

8:30 - 9:30 AM: “Pharmacotherapy of Bipolar Depressive Spectrum Disorders” - Joseph Goldberg, MD, Mount Sinai

9:30 - 10:30 AM: “Pharmacotherapies for Psychiatric Disorders: What Does The Future Hold” - Roger McIntyre, MD, University of Toronto

10:30 - 11:30 AM: “Pharmacotherapy of Schizophrenia” - Oliver Freudenreich, MD, Harvard 

11:30 - 11:45 AM: Break

11:45 AM - 12:45 PM:  Hot Topics (Six clinically relevant and topical issues for 8 minutes each)

12:45-2:00 PM: Lunch

2:00 – 3:00 PM: “Pharmacotherapy of Premenstrual, Perimenopausal and Postpartum Depression” - Jeff Newport, MD, University of Miami 

3:00 – 4:00 PM: “Pharmacotherapy of Antipsychotic Induced Movement Disorders” - Thomas Schwartz, MD, SUNY Upstate 

4:00 – 5:00 PM: “Pharmacotherapy of Narcolepsy and Insomnia” - Milton Erman, MD, University of California, San Diego

 

 

Day 2 - Sunday, September 9

7:30 – 8:30 AM: Breakfast

8:30 – 9:30 AM: “Pharmacotherapy of Anxiety Disorders” - James Murrough, MD, Mt. Sinai 

9:30 – 10:30 AM: “Pharmacotherapy of Binge Eating Disorder” - Carlos Grilo, PhD, Yale 

10:30 – 11:30 AM:  “Pharmacotherapy of ADHD Across The Life Cycle” - Anthony Rostain, MD, University of Pennsylvania

11:30 -11:45 AM: Break

11:45 AM – 12:45 PM: Hot Topics (Six clinically relevant and topical issues for 8 minutes each)

12:45 – 2:00 PM:  Lunch

2:00 – 3:00 PM: “Pharmacotherapy of Opioid and Alcohol Abuse Disorders in Psychiatric Patients” - Ashwin Patkar, MD, Duke

3:00 – 4:00 PM: “Pharmacotherapy of Treatment Resistant Mood Disorders” - Prakash Masand, MD, Duke-NUS 

 

 

Faculty Members Scheduled to Attend

Milton Erman, MD
Voluntary Clinical Professor in the Department of Psychiatry, School of Medicine of the University of California, San Diego
Oliver Freudenreich, MD
Associate Professor of Psychiatry
Harvard Medical School
Joseph F. Goldberg, MD
Clinical Professor of Psychiatry, Icahn School of Medicine, Mount Sinai
Carlos Grilo, PhD
Professor of Psychiatry, Yale University School of Medicine

 

 
Prakash Masand, MD
Chairman and CEO, Global Medical Education
Adjunct Professor, Duke-National University of Singapore Medical School
Roger S. McIntyre, MD
Professor of Psychiatry and Pharmacology
University of Toronto
James Murrough, MD
Associate Professor of Psychiatry and Neuroscience, Icahn School of Medicine at Mount Sinai
Jeff Newport, MD
Professor of Psychiatry and Behavioral Sciences, University of Miami
Ashwin A. Patkar, MD
Professor of Psychiatry
Duke University
Anthony Rostain, MD
Professor of Psychiatry and Pediatrics, Perelman School of Medicine
Thomas L. Schwartz, MD
Professor of Psychiatry and Director of Adult Psychiatric Clinical Services, SUNY Upstate Medical University

Location and Date

SATURDAY, SEPTEMBER 08-09, 2018
JW Marriott Washington, D.C.
1331 Pennsylvania Ave NW
Washington, D.C.

Join GME for Free!

Become a GME subscriber and gain full access to our extensive library of 700+ psychiatric medical education videos,
free CME webcasts, latest research updates, and more. To sample our content, watch the featured videos below.
Join Today!

GME Activities Calendar

NOVEMBER 03, 2018
Psychiatry Update 2018
Miami, FL SOLD OUT
NOVEMBER 17, 2018
Psychiatry Update 2018
Boston, MA SOLD OUT
NOVEMBER 30 - DECEMBER 01, 2018
Fifth Annual Mood Disorders Summit
Las Vegas , NV SOLD OUT
DECEMBER 02, 2018
Innovative Strategies for Managing Tardive Dyskinesia
Las Vegas , NV
JUNE 08, 2019
Psychiatry Update 2019
New York, NY
*Please note - business casual attire required. No jeans, sneakers or athletic wear allowed.
JUNE 22, 2019
Psychiatry Update 2019
Washington, D.C.
SEPTEMBER 07, 2019
Psychiatry Update 2019
Boston, MA
SEPTEMBER 20-21, 2019
6th Annual Mood Disorders Summit
Charleston, SC
SEPTEMBER 28, 2019
Psychiatry Update 2019
Chicago, IL
OCTOBER 05, 2019
Psychiatry Update 2019
West Palm Beach, FL
OCTOBER 12, 2019
Psychiatry Update 2019
Philadelphia, PA
OCTOBER 18-19, 2019
Fifth Annual Psychopharmacology Update
Scottsdale, AZ
OCTOBER 26, 2019
Psychiatry Update 2019
Dallas, TX
NOVEMBER 02, 2019
Psychiatry Update 2019
Atlanta, GA
NOVEMBER 16, 2019
Psychiatry Update 2019
San Francisco, CA
NOVEMBER 23, 2019
Psychiatry Update 2019
Scottsdale, AZ

To contact GME, email us at [email protected]


GME does not provide medical advice. The website and articles are intended for informational purposes only. They are not a substitute for professional medical advice, diagnosis or treatment. Never ignore professional medical advice in seeking treatment because of something you have read on the GME Website. If you think you may have a medical emergency, immediately call your doctor or dial 911.

Log In

Join GME For Free

Become a GME subscriber and gain full access to our extensive library of 700+ psychiatric medical education videos, free CME webcasts, latest research updates, and more. To sample our content, watch the featured videos below.
Join Today!